Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Logitech International SA (LOGI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Logitech International SA — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $111.12 (market cap $12.58B), while Logitech International SA trades at $100.23 (market cap $14.46B). The key difference: Halozyme Therapeutics Inc. Common Stock and Logitech International SA are close in size by market cap, and Logitech International SA pays a 1.63% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and Logitech International SA for 92 Days on average.
| HALO | LOGI | |
|---|---|---|
Market Cap | $12.58B | $14.46B |
Volume | 2,179,278 | 349,547 |
Sector | Health | Technology |
52-Week High | $115.22 | $126.69 |
52-Week Low | $61.63 | $85.84 |
Typical Hold Time | 0 Days | 92 Days |
Enterprise Value | $14.49B | $12.79B |
Dividend Yield | — | 1.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Logitech (LOGI) trades at $100.70, down 1.45% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $107.00. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of $1.85 surpassing the $1.26 estimate. The company maintains strong profitability, including a 16.28% net income margin and 35.29% ROE, and has announced new product launches like the Zone Vibe Pro headset and a partnership with SEGA.
The outlook is supported by solid fundamentals and positive product news, but risks include competitive pressures and macroeconomic sensitivity. Analyst sentiment is mixed, with a Hold consensus, suggesting cautious optimism. Upside potential exists if the company continues its earnings beat streak and navigates supply chain challenges effectively.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Logitech International SA
Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →
